Lobular Breast Cancer: Comprehensive Overview by Dr. Lizza Raiden
Introduction
- Presenter: Dr. Lizza Raiden
- Personal Experience: Mixed ductal and lobular breast cancer since 2015
- Purpose: To provide information on lobular breast cancer (LBC)
What is Lobular Breast Cancer?
- Develops from glandular tissue in the breast
- Comprises 10-15% of all breast cancers
- Common in menopausal women
- Often ER positive and HER2 negative
- Tends to be larger and multifocal
- Possibly bilateral at diagnosis
- Rare type: Pleomorphic Lobular Breast Cancer
Detection Challenges
- Lobular cancer cells grow in sheets, not clumps
- Harder to detect on mammograms
- Detected better via ultrasound and MRI
- Occult cancers can still be missed
Symptoms and Signs
- Symptoms include skin dimpling, fuller breast, nipple inversion
- Hard to detect through self-examination
Diagnosis Methods
- Mammogram: picks up 2/3 of lobular cancers
- Ultrasound: detects 90% of lobular cancers
- MRI: detects 95% of lobular cancers
Treatment Approaches
- Surgery: Lumpectomy or mastectomy to remove cancer with clear margins
- Chemotherapy: Less effective for slow-growing lobular cancers
- Hormonal Therapy: Main treatment, aiming to lower estrogen levels
- Often combined with CDK inhibitors
- Targeted Therapy: E.g. CDK4/6 inhibitors
Recurrence and Metastasis
- Lobular cancer can recur 10-20 years post-treatment
- Metastasizes to liver, bones, abdominal cavity
- Symptoms: indigestion, constipation, urinary difficulties
Research and Future Directions
- Immunotherapy: Trials like Gelato examining new treatment options
- Genetic Mutations: Investigation into mutations like PIK3CA and CDH1 genes
- Liquid Biopsies: Potential future diagnostic method
Personal Story and Advice
- Regular self-checks and professional consultations critical
- Ask for regular MRI if previous mammograms missed the cancer
Conclusion
- Continuous research is pivotal
- Patients encouraged to stay informed and proactive in management
- Links to support and further information provided
Subscribe to Dr. Lizza Raiden for more updates.